Skip to main content

Articles

Page 9 of 60

  1. A new definition of metabolically healthy obesity (MHO) has recently been proposed to stratify the heterogeneous mortality risk of obesity. Metabolomic profiling provides clues to metabolic alterations beyond ...

    Authors: Dongmei Wei, Vannina González-Marrachelli, Jesus D Melgarejo, Chia-Te Liao, Angie Hu, Stefan Janssens, Peter Verhamme, Lucas Van Aelst, Thomas Vanassche, Josep Redon, Maria Tellez-Plaza, Juan C Martin-Escudero, Daniel Monleon and Zhen-Yu Zhang
    Citation: Cardiovascular Diabetology 2023 22:82
    Content type: Research Published on:

  2. Coronary artery calcium (CAC) improves cardiovascular event prediction. Visceral adipose tissue (VAT) is a cardiometabolic risk factor that may directly or through its related comorbidities determine the obesi...

    Authors: Neftali Eduardo Antonio-Villa, Juan Gabriel Juárez-Rojas, Rosalinda Posadas-Sánchez, Juan Reyes-Barrera and Aida Medina-Urrutia
    Citation: Cardiovascular Diabetology 2023 22:81
    Content type: Research Published on:

  3. Sodium–glucose transporter 2 inhibitors (SGLT2-I) could modulate atherosclerotic plaque progression, via down-regulation of inflammatory burden, and lead to reduction of major adverse cardiovascular events (MA...

    Authors: Celestino Sardu, Maria Consiglia Trotta, Ferdinando Carlo Sasso, Cosimo Sacra, Gerardo Carpinella, Ciro Mauro, Fabio Minicucci, Paolo Calabrò, Michele D’ Amico, Fabrizio D’ Ascenzo, Ovidio De Filippo, Mario Iannaccone, Carmine Pizzi, Giuseppe Paolisso and Raffaele Marfella
    Citation: Cardiovascular Diabetology 2023 22:80
    Content type: Research Published on:

  4. Due to their cardiovascular protective effect, glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) represent breakthrough therapies for type 2 diabetes ...

    Authors: Pierre Gourdy, Patrice Darmon, François Dievart, Jean-Michel Halimi and Bruno Guerci
    Citation: Cardiovascular Diabetology 2023 22:79
    Content type: Review Published on:

  5. Diffuse myocardial fibrosis and microvascular dysfunction are suggested to underlie cardiac dysfunction in patients with type 2 diabetes, but studies investigating their relative impact are lacking. We aimed t...

    Authors: Annemie S. Bojer, Martin H. Sørensen, Stine H. Madsen, David A. Broadbent, Sven Plein, Peter Gæde and Per L. Madsen
    Citation: Cardiovascular Diabetology 2023 22:78
    Content type: Research Published on:

  6. Diabetes mellitus (DM) type 2 is an independent risk factor for atrial fibrillation (AF). Surgical ablation or "maze procedure" is an option for patients with AF undergoing concomitant or isolated cardiac surg...

    Authors: Alexander Kogan, Avishay Grupper, Avi Sabbag, Eilon Ram, Tamer Jamal, Eyal Nof, Enrique Z. Fisman, Shany Levin, Roy Beinart, Jonathan Frogel, Ehud Raanani and Leonid Sternik
    Citation: Cardiovascular Diabetology 2023 22:77
    Content type: Research Published on:

    The Correction to this article has been published in Cardiovascular Diabetology 2023 22:116

  7. Previous studies have shown that the stress hyperglycemia ratio (SHR), a parameter of relative stress-induced hyperglycemia, is an excellent predictive factor for all-cause mortality and major adverse cardiova...

    Authors: Zehuo Lin, Xueqing Liang, Yeshen Zhang, Yining Dai, Lin Zeng, Weikun Chen, Siyu Kong, Pengcheng He, Chongyang Duan and Yuanhui Liu
    Citation: Cardiovascular Diabetology 2023 22:76
    Content type: Research Published on:

  8. The triglyceride glucose-body mass index (TyG-BMI index) has been considered a reliable surrogate measure of insulin resistance; however, its ability to predict the incidence of cardiovascular disease in indiv...

    Authors: Yang Cheng, Zhen Fang, Xinxin Zhang, Yuchen Wen, Jiaqi Lu, Shenghu He and Bing Xu
    Citation: Cardiovascular Diabetology 2023 22:75
    Content type: Research Published on:

  9. Chronic kidney disease (CKD) is a common comorbidity in people with diabetes mellitus, and a key risk factor for further life-threatening conditions such as cardiovascular disease. The early prediction of prog...

    Authors: Michael Kammer, Andreas Heinzel, Karin Hu, Heike Meiselbach, Mariella Gregorich, Martin Busch, Kevin L. Duffin, Maria F. Gomez, Kai-Uwe Eckardt and Rainer Oberbauer
    Citation: Cardiovascular Diabetology 2023 22:74
    Content type: Research Published on:

  10. Cardiovascular diseases, including diabetic cardiomyopathy, are major causes of death in people with type 2 diabetes. Aldose reductase activity is enhanced in hyperglycemic conditions, leading to altered cardi...

    Authors: Keshav Gopal, Qutuba G. Karwi, Seyed Amirhossein Tabatabaei Dakhili, Cory S. Wagg, Liyan Zhang, Qiuyu Sun, Christina T. Saed, Sai Panidarapu, Riccardo Perfetti, Ravichandran Ramasamy, John R. Ussher and Gary D. Lopaschuk
    Citation: Cardiovascular Diabetology 2023 22:73
    Content type: Research Published on:

  11. Estimating cardiovascular (CV) event accrual is important for outcome trial planning. Limited data exist describing event accrual patterns in patients with type 2 diabetes (T2D). We compared apparent CV event ...

    Authors: M. Angelyn Bethel, Harald Sourij, Susanna R. Stevens, Karen Hannan, Yuliya Lokhnygina, Amanda I. Adler, Eric D. Peterson, Rury R. Holman and Renato D. Lopes
    Citation: Cardiovascular Diabetology 2023 22:72
    Content type: Research Published on:

  12. High-density lipoprotein cholesterol’s (HDL-C) long-held status as a cardiovascular disease (CVD) preventative has been called into question. Most of the evidence, however, focused on either the risk of death ...

    Authors: Hye Jun Kim, Seogsong Jeong, Yun Hwan Oh, Sun Jae Park, Yoosun Cho and Sang Min Park
    Citation: Cardiovascular Diabetology 2023 22:71
    Content type: Research Published on:

  13. Although albuminuria has been linked to heart failure in the general population, the relationship between urine albumin-to-creatinine ratio (uACR) and heart failure in type 2 diabetes patients is not well unde...

    Authors: Jie Tao, Dasen Sang, Libo Zhen, Xinxin Zhang, Yuejun Li, Guodong Wang, Shuohua Chen, Shouling Wu and Wenjuan Zhang
    Citation: Cardiovascular Diabetology 2023 22:70
    Content type: Research Published on:

  14. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have shown cardiovascular benefits in cardiovascular outcome trials in type 2 diabetes mellitus. However, the most convincing evidence was obtained in subj...

    Authors: Sara Piccini, Giuseppe Favacchio, Cristina Panico, Emanuela Morenghi, Franco Folli, Gherardo Mazziotti, Andrea Gerardo Lania and Marco Mirani
    Citation: Cardiovascular Diabetology 2023 22:69
    Content type: Research Published on:

  15. Prediabetes is common and associated with poor prognosis in patients with acute coronary syndrome and those undergoing revascularization. However, the impact of prediabetes on prognosis in patients with corona...

    Authors: Chenxi Song, Sheng Yuan, Kongyong Cui, Zhongxing Cai, Rui Zhang, Jining He, Zheng Qiao, Xiaohui Bian, Shaoyu Wu, Haoyu Wang, Boqun Shi, Zhangyu Lin, Rui Fu, Chunyue Wang, Qianqian Liu, Lei Jia…
    Citation: Cardiovascular Diabetology 2023 22:68
    Content type: Research Published on:

  16. Microvascular dysfunction (MVD) is an important contributor to major clinical disease such as stroke, dementia, depression, retinopathy, and chronic kidney disease. Alcohol consumption may be a determinant of ...

    Authors: Frank C. T. van der Heide, Simone J. P. M. Eussen, Alfons J. H. M. Houben, Ronald M. A. Henry, Abraham A. Kroon, Carla J. H. van der Kallen, Pieter C. Dagnelie, Martien C. J. M. van Dongen, Tos T. J. M. Berendschot, Jan S. A. G. Schouten, Carroll A. B. Webers, Marleen M. J. van Greevenbroek, Anke Wesselius, Casper G. Schalkwijk, Annemarie Koster, Jacobus F. A. Jansen…
    Citation: Cardiovascular Diabetology 2023 22:67
    Content type: Research Published on:

  17. Tirzepatide, a once-weekly glucose-dependent insulinotropic polypeptide/ glucagon-like peptide-1 receptor agonist, is approved in the United States, Europe and Japan for the treatment of type 2 diabetes. Acros...

    Authors: Ildiko Lingvay, Ofri Mosenzon, Katelyn Brown, Xuewei Cui, Ciara O’Neill, Laura Fernández Landó and Hiren Patel
    Citation: Cardiovascular Diabetology 2023 22:66
    Content type: Research Published on:

  18. To investigate the prognostic value of computed tomography fractional flow reserve (CT-FFR) in patients with diabetes and to establish a risk stratification model for major adverse cardiac event (MACE).

    Authors: Ziting Lan, Xiaoying Ding, Yarong Yu, Lihua Yu, Wenli Yang, Xu Dai, Runjianya Ling, Yufan Wang, Wenyi Yang and Jiayin Zhang
    Citation: Cardiovascular Diabetology 2023 22:65
    Content type: Research Published on:

  19. Recent reports suggested a different predictive value for TyG index compared to HOMA-IR in coronary artery calcification (CAC) and other atherosclerotic outcomes, despite that both indices are proposed as surr...

    Authors: Ákos Nádasdi, Viktor Gál, Tamás Masszi, Anikó Somogyi and Gábor Firneisz
    Citation: Cardiovascular Diabetology 2023 22:64
    Content type: Research Published on:

  20. It is now understood that stress hyperglycemia is associated with adverse outcomes in hospitalized patients. Herein, we aimed to investigate the association between stress hyperglycemia and mortality risk in a...

    Authors: Man Wang, Wen Su, Ning Cao, Hui Chen and Hongwei Li
    Citation: Cardiovascular Diabetology 2023 22:63
    Content type: Research Published on:

  21. Effects of antihyperglycemic therapies on cardiovascular and heart failure (HF) risks have varied widely across cardiovascular outcome trials (CVOTs), and underlying factors remain incompletely understood. We ...

    Authors: Masashi Hasebe, Satoshi Yoshiji, Yamato Keidai, Hiroto Minamino, Takaaki Murakami, Daisuke Tanaka, Yoshihito Fujita, Norio Harada, Akihiro Hamasaki and Nobuya Inagaki
    Citation: Cardiovascular Diabetology 2023 22:62
    Content type: Research Published on:

    The Correction to this article has been published in Cardiovascular Diabetology 2023 22:95

  22. The aim of this study was to investigate the association between estimated glucose disposal rate (eGDR), a proxy for insulin resistance, and retinopathy or kidney disease, i.e. micro-, or macroalbuminuria, in ...

    Authors: Wedén Linn, Martina Persson, Björn Rathsman, Johnny Ludvigsson, Marcus Lind, Mikael Andersson Franko and Thomas Nyström
    Citation: Cardiovascular Diabetology 2023 22:61
    Content type: Research Published on:

  23. To determine whether glucagon-like peptide 1 receptor agonists (GLP-1RAs) have cardiovascular and renal protective effects in patients with advanced diabetic kidney disease (DKD) with an estimated glomerular f...

    Authors: Yuan Lin, Te-Hsiung Wang, Ming-Lung Tsai, Victor Chien-Chia Wu, Chin-Ju Tseng, Ming-Shyan Lin, Yan-Rong Li, Chih-Hsiang Chang, Tien-Shin Chou, Tzu-Hsien Tsai, Ning-I Yang, Ming-Jui Hung and Tien-Hsing Chen
    Citation: Cardiovascular Diabetology 2023 22:60
    Content type: Research Published on:

  24. The 8th Cardiovascular Outcome Trial (CVOT) Summit on Cardiovascular, Kidney, and Glycemic Outcomes was held virtually on November 10–12, 2022. Following the tradition of previous summits, this reference congr...

    Authors: Oliver Schnell, Tadej Battelino, Richard Bergenstal, Andreas L. Birkenfeld, Antonio Ceriello, Alice Cheng, Melanie Davies, Steve Edelman, Thomas Forst, Francesco Giorgino, Jennifer Green, Per-Henrik Groop, Samy Hadjadj, Hiddo J.L.Heerspink, Marcus Hompesch, Baruch Izthak…
    Citation: Cardiovascular Diabetology 2023 22:59
    Content type: Comment Published on:

  25. Previous studies showed that the triglyceride-glucose (TyG) index was a better predictor of adverse cardiovascular events than triglycerides or fasting blood glucose alone. However, few studies have focused on...

    Authors: Qi Gao, Yuxin Lin, Ruqi Xu, Fan Luo, Ruixuan Chen, Pingping Li, Yuping Zhang, Jiao Liu, Zhenan Deng, Yanqin Li, Licong Su and Sheng Nie
    Citation: Cardiovascular Diabetology 2023 22:58
    Content type: Research Published on:

  26. Patients with type 2 diabetes are at increased risk for cardiovascular diseases. Sodium-glucose transport 2 inhibitors (SGLT2i) have been shown to enhance cardiovascular health since their debut as a second-li...

    Authors: Pei-Chien Tsai, Wei-Jung Chuang, Albert Min-Shan Ko, Jui-Shuan Chen, Cheng-Hsun Chiu, Chun-Han Chen and Yung-Hsin Yeh
    Citation: Cardiovascular Diabetology 2023 22:57
    Content type: Research Published on:

  27. The triglyceride–glucose (TyG) index has been shown to be an independent predictor for the progression and prognosis of coronary artery disease (CAD). Whether the TyG index predicts the severity of CAD in pati...

    Authors: Shiqiang Xiong, Qiang Chen, Yu Long, Hong Su, Yan Luo, Hanxiong Liu, Yingzhong Chen, Qiao Feng, Xiufen Peng, Maoling Jiang, Xiuqiong Yu, Zhen Zhang and Lin Cai
    Citation: Cardiovascular Diabetology 2023 22:56
    Content type: Research Published on:

  28. Diabetes mellitus (DM) is considered a major risk factor for myocardial infarction (MI), and MI patients with DM have a poor prognosis. Accordingly, we aimed to investigate the additive effects of DM on LV def...

    Authors: Yue Gao, Rui Shi, Yuan Li, Ying-kun Guo, Hua-Yan Xu, Ke Shi and Zhi-gang Yang
    Citation: Cardiovascular Diabetology 2023 22:55
    Content type: Research Published on:

  29. No study has compared the cardiovascular outcomes for sodium–glucose cotransporter-2 inhibitors (SGLT2i) head-to-head against other glucose-lowering therapies, including dipeptidyl peptidase 4 inhibitor (DDP4i...

    Authors: Jimmy Gonzalez, Benjamin A. Bates, Soko Setoguchi, Tobias Gerhard and Chintan V. Dave
    Citation: Cardiovascular Diabetology 2023 22:54
    Content type: Research Published on:

  30. To evaluate the protective effect of oral antidiabetic drugs in a large cohort of elderly patients with type 2 diabetes differing for age, clinical status, and life expectancy, including patients with multiple...

    Authors: Federico Rea, Laura Savaré, Valeria Valsassina, Stefano Ciardullo, Gianluca Perseghin, Giovanni Corrao and Giuseppe Mancia
    Citation: Cardiovascular Diabetology 2023 22:53
    Content type: Research Published on:

  31. In clinical practice, anthropometric measures other than BMI are rarely assessed yet may be more predictive of cardiovascular (CV) risk. We analyzed the placebo group of the REWIND CV Outcomes Trial to compare...

    Authors: Edward Franek, Prem Pais, Jan Basile, Claudia Nicolay, Sohini Raha, Ana Hickey, Nadia N. Ahmad, Manige Konig, Hong Kan and Hertzel C. Gerstein
    Citation: Cardiovascular Diabetology 2023 22:52
    Content type: Research Published on:

  32. Diabetes mellitus (DM) is a well-established determinant of atherosclerosis and cardiovascular diseases (CVD). Recently, genome-wide association studies (GWAS) identified several single nucleotide polymorphism...

    Authors: Tzu-Wei Wu, Chao-Liang Chou, Chun-Fang Cheng, Shu-Xin Lu, Yih-Jer Wu and Li-Yu Wang
    Citation: Cardiovascular Diabetology 2023 22:51
    Content type: Research Published on:

  33. Basal insulin glargine has a neutral effect on cardiovascular risk in type 2 diabetes (T2DM). In practice, basal insulin is often paired with a glucagon-like peptide-1 receptor agonist (GLP1-RA) or meal insuli...

    Authors: Ravi Retnakaran, Jiajie Pu, Chang Ye, Alexandra Emery, Caroline K. Kramer and Bernard Zinman
    Citation: Cardiovascular Diabetology 2023 22:50
    Content type: Research Published on:

  34. Patients with type 2 diabetes (T2D) treated with glucagon-like peptide-1 receptor agonists may experience reductions in weight and blood pressure. The primary objective of the current study was to determine th...

    Authors: Keith C. Ferdinand, Julia Dunn, Claudia Nicolay, Flora Sam, Emily K. Blue and Hui Wang
    Citation: Cardiovascular Diabetology 2023 22:49
    Content type: Research Published on:

  35. Ectopic fat is fat that accumulates in or around specific organs or compartments of the body including myocardium. The clinical features of type 2 diabetes patients with high fat accumulation in the myocardium...

    Authors: Risa Kashiwagi-Takayama, Junji Kozawa, Yoshiya Hosokawa, Sarasa Kato, Satoshi Kawata, Harutoshi Ozawa, Ryohei Mineo, Chisaki Ishibashi, Megu Y. Baden, Ryuya Iwamoto, Kenji Saisho, Yukari Fujita, Sachiko Tamba, Takuya Sugiyama, Hitoshi Nishizawa, Norikazu Maeda…
    Citation: Cardiovascular Diabetology 2023 22:48
    Content type: Research Published on:

  36. Both long-term glycaemic variability and arterial stiffness have been recognized as cardiovascular risk factors. This study aims to investigate whether an association between these phenomena exists in individu...

    Authors: Anniina Tynjälä, Valma Harjutsalo, Fanny Jansson Sigfrids, Per-Henrik Groop and Daniel Gordin
    Citation: Cardiovascular Diabetology 2023 22:47
    Content type: Research Published on:

    The Correction to this article has been published in Cardiovascular Diabetology 2023 22:83

  37. To examine the joint association of diabetes status and N-terminal pro-B-type natriuretic peptide (NT-proBNP) with subsequent risk of major adverse cardio-cerebral events (MACCEs) and all-cause mortality in pa...

    Authors: Man Wang, Wen Su, Hui Chen and Hongwei Li
    Citation: Cardiovascular Diabetology 2023 22:46
    Content type: Research Published on:

  38. Epicardial adipose tissue (EAT) accumulation is associated with multiple cardiometabolic risk factors and prognosis of heart failure with preserved ejection fraction (HFpEF). The correlation between EAT densit...

    Authors: Jie Liu, Qi Yu, Ziyang Li, Yujiao Zhou, Zhiqiang Liu, Linna You, Li Tao, Qian Dong, Ziyu Zuo, Lei Gao and Dongying Zhang
    Citation: Cardiovascular Diabetology 2023 22:45
    Content type: Research Published on:

  39. Obesity is a negative chronic metabolic health condition that represents an additional risk for the development of multiple pathologies. Epidemiological studies have shown how maternal obesity or gestational d...

    Authors: Juan José Alba-Linares, Raúl F. Pérez, Juan Ramón Tejedor, David Bastante-Rodríguez, Francisco Ponce, Nuria García Carbonell, Rafael Gómez Zafra, Agustín F. Fernández, Mario F. Fraga and Empar Lurbe
    Citation: Cardiovascular Diabetology 2023 22:44
    Content type: Research Published on:

  40. The triglyceride-glucose (TyG) index, a reliable surrogate indicator of insulin resistance, is independently associated with coronary artery disease of various clinical manifestations. This study aimed to inve...

    Authors: Xuantong Guo, Ruihuan Shen, Siyu Yan, Yanni Su and Lihong Ma
    Citation: Cardiovascular Diabetology 2023 22:43
    Content type: Research Published on:

  41. The prevalence of prediabetes is increasing in young adults and patients undergoing coronary angiography. However, whether prediabetes is a considerable risk factor for all-cause mortality remains undetermined...

    Authors: Yibo He, Hongyu Lu, Yihang Ling, Jin Liu, Sijia Yu, Ziyou Zhou, Tian Chang, Yong Liu, Shiqun Chen and Jiyan Chen
    Citation: Cardiovascular Diabetology 2023 22:42
    Content type: Research Published on:

    The Correction to this article has been published in Cardiovascular Diabetology 2023 22:155

  42. Identifying and reducing cardiometabolic risks driven by obesity remains a healthcare challenge. The metabolic syndrome is associated with abdominal obesity and inflammation and is predictive of long-term risk...

    Authors: Rasmus M. Sandsdal, Christian R. Juhl, Simon B. K. Jensen, Julie R. Lundgren, Charlotte Janus, Martin B. Blond, Mads Rosenkilde, Adrian F. Bogh, Lasse Gliemann, Jens-Erik B. Jensen, Charalambos Antoniades, Bente M. Stallknecht, Jens J. Holst, Sten Madsbad and Signe S. Torekov
    Citation: Cardiovascular Diabetology 2023 22:41
    Content type: Research Published on:

  43. There are limited data on head-to-head comparative risk of stroke between sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA). We compared risk of stroke ...

    Authors: David Tak Wai Lui, Eric Ho Man Tang, Tingting Wu, Ivan Chi Ho Au, Chi Ho Lee, Yu Cho Woo, Kathryn Choon Beng Tan and Carlos King Ho Wong
    Citation: Cardiovascular Diabetology 2023 22:40
    Content type: Research Published on:

  44. Red cell distribution width/albumin ratio (RAR) is thought to be associated with the prognosis of a variety of diseases, including diabetes and heart failure. To date, no studies have focused on the relationsh...

    Authors: Mengnan Huang, Fanfan Liu, Zhu Li, Yijia Liu, Jinyu Su, Mei Ma, Yuanyuan He, Huaien Bu, Shan Gao, Hongwu Wang and Chunquan Yu
    Citation: Cardiovascular Diabetology 2023 22:39
    Content type: Research Published on:

  45. Diabetes mellitus (DM) is associated with various cardiovascular complications, including sudden cardiac arrest (SCA). Furthermore, the severity of DM, as assessed by fasting blood glucose (FBG), is associated...

    Authors: Yun Gi Kim, Seung-Young Roh, Joo Hee Jeong, Hyoung Seok Lee, Kyongjin Min, Yun Young Choi, Kyung-Do Han, Jaemin Shim, Jong-Il Choi and Young-Hoon Kim
    Citation: Cardiovascular Diabetology 2023 22:38
    Content type: Research Published on:

  46. Diabetes mellitus is one of the prime risk factors for cardiovascular complications and is linked with high morbidity and mortality. Diabetic cardiomyopathy (DCM) often manifests as reduced cardiac contractili...

    Authors: Santosh K Sanganalmath, Shubham Dubey, Sudhakar Veeranki, Keerthy Narisetty and Prasanna Krishnamurthy
    Citation: Cardiovascular Diabetology 2023 22:37
    Content type: Review Published on:

  47. Dyslipidemia measured as low-density lipoprotein (LDL)-cholesterol is an established risk factor of cardiovascular disease, which is more pronounced in diabetes population. Less is known about the association ...

    Authors: Yun Gi Kim, Joo Hee Jeong, Kyung-Do Han, Seung-Young Roh, Kyongjin Min, Hyoung Seok Lee, Yun Young Choi, Jaemin Shim, Jong-Il Choi and Young-Hoon Kim
    Citation: Cardiovascular Diabetology 2023 22:36
    Content type: Research Published on:

  48. The glycemic continuum often indicates a gradual decline in insulin sensitivity leading to an increase in glucose levels. Although prediabetes is an established risk factor for both macrovascular and microvasc...

    Authors: Jung-Chi Hsu, Yen-Yun Yang, Shu-Lin Chuang, Lian-Yu Lin and Tony Hsiu-Hsi Chen
    Citation: Cardiovascular Diabetology 2023 22:35
    Content type: Research Published on:

  49. The triglyceride-glucose (TyG) index and triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio, two simple surrogate indicators of insulin resistance, have been demonstrated to predict cardiova...

    Authors: Bizhong Che, Chongke Zhong, Ruijie Zhang, Liyuan Pu, Tian Zhao, Yonghong Zhang and Liyuan Han
    Citation: Cardiovascular Diabetology 2023 22:34
    Content type: Research Published on:

  50. The 2019 guidelines for cardiovascular risk stratification by the European Society of Cardiology and European Association for the Study of Diabetes (ESC-EASD) suggested screening for silent coronary disease in...

    Authors: Paul Valensi, Narimane Berkane, Sara Pinto, Nicolas Sellier, Michael Soussan, Minh Tuan Nguyen and Emmanuel Cosson
    Citation: Cardiovascular Diabetology 2023 22:33
    Content type: Research Published on:
journal logo

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Submit manuscript

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    56 days submission to accept (Median)

    2023 Usage 
    2,523,778 downloads
    3,115 Altmetric mentions 

Cardiovascular Diabetology

ISSN: 1475-2840